{"title":"括约肌切开术与用于缓解奥奇氏括约肌功能障碍患者疼痛的假手术:系统回顾和元分析","authors":"Dennis Wang, Kayla Dadgar, Mohammad Yaghoobi","doi":"10.1016/j.tige.2023.10.003","DOIUrl":null,"url":null,"abstract":"<div><h3>Background and Aims</h3><p><span><span>Endoscopic sphincterotomy (ES) used to be part of </span>sphincter of Oddi dysfunction (SOD) management, but recent studies changed attitudes about its utility. We conducted a </span>systematic review and meta-analysis of randomized sham-controlled trials (RCTs) investigating ES for biliary SOD-related pain.</p></div><div><h3>Methods</h3><p>Articles were retrieved from PubMed, Medline, Embase, and CENTRAL. We included RCTs comparing ES with a sham procedure<span> on post-cholecystectomy patients ≥18 years old with biliary SOD. Standardized data collection sheets were used, as well as the Risk of Bias 2 tool. A random-effects model was used to calculate risk ratios (RRs) with 95% confidence intervals (CIs). Subgroups included normal vs abnormal sphincter of Oddi manometry (SOM) and type II vs III SOD.</span></p></div><div><h3>Results</h3><p>From 517 articles retrieved, 4 RCTs were included, encompassing 376 patients. Overall, no difference existed between ES and the sham procedure in improving biliary SOD-related pain overall (RR 1.32, 95% CI 0.77-2.26, <em>P</em> = .31) and for the normal (RR 0.83, 95% CI 0.42-1.65, <em>P</em> = .60) and abnormal SOM subgroups (RR 1.90, 95% CI 0.84-4.29, <em>P</em><span> = .12). ES was numerically favored over the sham procedure in patients with type II (RR 2.51, 95% CI 1.32-4.81, </span><em>P</em> = .005) but not type III SOD (RR 1.02, 95% CI 0.32-3.27, <em>P</em> = .98). However, there was no significant subgroup difference between these type-based subgroups (<em>P</em> = .18, I<sup>2</sup> = 43.2%).</p></div><div><h3>Conclusion</h3><p>ES does not improve biliary SOD-related pain overall or for type II vs III SOD or normal vs abnormal SOM subgroups. This meta-analysis confirms that there is no proven role for SOM or ES in managing SOD.</p></div>","PeriodicalId":36169,"journal":{"name":"Techniques and Innovations in Gastrointestinal Endoscopy","volume":"26 1","pages":"Pages 30-37"},"PeriodicalIF":1.2000,"publicationDate":"2024-01-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":"0","resultStr":"{\"title\":\"Sphincterotomy vs Sham Procedure for Pain Relief in Sphincter of Oddi Dysfunction: Systematic Review and Meta-analysis\",\"authors\":\"Dennis Wang, Kayla Dadgar, Mohammad Yaghoobi\",\"doi\":\"10.1016/j.tige.2023.10.003\",\"DOIUrl\":null,\"url\":null,\"abstract\":\"<div><h3>Background and Aims</h3><p><span><span>Endoscopic sphincterotomy (ES) used to be part of </span>sphincter of Oddi dysfunction (SOD) management, but recent studies changed attitudes about its utility. We conducted a </span>systematic review and meta-analysis of randomized sham-controlled trials (RCTs) investigating ES for biliary SOD-related pain.</p></div><div><h3>Methods</h3><p>Articles were retrieved from PubMed, Medline, Embase, and CENTRAL. We included RCTs comparing ES with a sham procedure<span> on post-cholecystectomy patients ≥18 years old with biliary SOD. Standardized data collection sheets were used, as well as the Risk of Bias 2 tool. A random-effects model was used to calculate risk ratios (RRs) with 95% confidence intervals (CIs). Subgroups included normal vs abnormal sphincter of Oddi manometry (SOM) and type II vs III SOD.</span></p></div><div><h3>Results</h3><p>From 517 articles retrieved, 4 RCTs were included, encompassing 376 patients. Overall, no difference existed between ES and the sham procedure in improving biliary SOD-related pain overall (RR 1.32, 95% CI 0.77-2.26, <em>P</em> = .31) and for the normal (RR 0.83, 95% CI 0.42-1.65, <em>P</em> = .60) and abnormal SOM subgroups (RR 1.90, 95% CI 0.84-4.29, <em>P</em><span> = .12). ES was numerically favored over the sham procedure in patients with type II (RR 2.51, 95% CI 1.32-4.81, </span><em>P</em> = .005) but not type III SOD (RR 1.02, 95% CI 0.32-3.27, <em>P</em> = .98). However, there was no significant subgroup difference between these type-based subgroups (<em>P</em> = .18, I<sup>2</sup> = 43.2%).</p></div><div><h3>Conclusion</h3><p>ES does not improve biliary SOD-related pain overall or for type II vs III SOD or normal vs abnormal SOM subgroups. This meta-analysis confirms that there is no proven role for SOM or ES in managing SOD.</p></div>\",\"PeriodicalId\":36169,\"journal\":{\"name\":\"Techniques and Innovations in Gastrointestinal Endoscopy\",\"volume\":\"26 1\",\"pages\":\"Pages 30-37\"},\"PeriodicalIF\":1.2000,\"publicationDate\":\"2024-01-01\",\"publicationTypes\":\"Journal Article\",\"fieldsOfStudy\":null,\"isOpenAccess\":false,\"openAccessPdf\":\"\",\"citationCount\":\"0\",\"resultStr\":null,\"platform\":\"Semanticscholar\",\"paperid\":null,\"PeriodicalName\":\"Techniques and Innovations in Gastrointestinal Endoscopy\",\"FirstCategoryId\":\"1085\",\"ListUrlMain\":\"https://www.sciencedirect.com/science/article/pii/S2590030723000740\",\"RegionNum\":0,\"RegionCategory\":null,\"ArticlePicture\":[],\"TitleCN\":null,\"AbstractTextCN\":null,\"PMCID\":null,\"EPubDate\":\"\",\"PubModel\":\"\",\"JCR\":\"Q4\",\"JCRName\":\"GASTROENTEROLOGY & HEPATOLOGY\",\"Score\":null,\"Total\":0}","platform":"Semanticscholar","paperid":null,"PeriodicalName":"Techniques and Innovations in Gastrointestinal Endoscopy","FirstCategoryId":"1085","ListUrlMain":"https://www.sciencedirect.com/science/article/pii/S2590030723000740","RegionNum":0,"RegionCategory":null,"ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":null,"EPubDate":"","PubModel":"","JCR":"Q4","JCRName":"GASTROENTEROLOGY & HEPATOLOGY","Score":null,"Total":0}
引用次数: 0
摘要
背景和目的内镜下括约肌切开术(ES)曾是奥奇括约肌功能障碍(SOD)治疗的一部分,但最近的研究改变了人们对其效用的看法。我们对研究 ES 治疗胆道 SOD 相关疼痛的随机假对照试验(RCT)进行了系统回顾和荟萃分析。我们纳入了对胆囊切除术后年龄≥18 岁的胆道 SOD 患者进行 ES 与假手术比较的 RCT。我们使用了标准化数据收集表和偏倚风险 2 工具。采用随机效应模型计算风险比 (RR) 和 95% 置信区间 (CI)。亚组包括正常与异常Oddi括约肌测压(SOM)和II型与III型SOD。结果从检索到的517篇文章中,共纳入了4项RCT,涉及376名患者。总体而言,ES 与假手术在改善胆道 SOD 相关疼痛方面没有差异(RR 1.32,95% CI 0.77-2.26,P = .31),正常(RR 0.83,95% CI 0.42-1.65,P = .60)和异常 SOM 亚组(RR 1.90,95% CI 0.84-4.29,P = .12)也没有差异。在 II 型(RR 2.51,95% CI 1.32-4.81,P = .005)而非 III 型 SOD(RR 1.02,95% CI 0.32-3.27,P = .98)患者中,ES 在数字上优于假手术。然而,这些基于类型的亚组之间没有明显的亚组差异(P = .18,I2 = 43.2%)。结论ES不能改善总体胆道SOD相关疼痛,也不能改善II型与III型SOD或正常与异常SOM亚组的疼痛。这项荟萃分析证实,SOM 或 ES 在控制 SOD 方面没有公认的作用。
Sphincterotomy vs Sham Procedure for Pain Relief in Sphincter of Oddi Dysfunction: Systematic Review and Meta-analysis
Background and Aims
Endoscopic sphincterotomy (ES) used to be part of sphincter of Oddi dysfunction (SOD) management, but recent studies changed attitudes about its utility. We conducted a systematic review and meta-analysis of randomized sham-controlled trials (RCTs) investigating ES for biliary SOD-related pain.
Methods
Articles were retrieved from PubMed, Medline, Embase, and CENTRAL. We included RCTs comparing ES with a sham procedure on post-cholecystectomy patients ≥18 years old with biliary SOD. Standardized data collection sheets were used, as well as the Risk of Bias 2 tool. A random-effects model was used to calculate risk ratios (RRs) with 95% confidence intervals (CIs). Subgroups included normal vs abnormal sphincter of Oddi manometry (SOM) and type II vs III SOD.
Results
From 517 articles retrieved, 4 RCTs were included, encompassing 376 patients. Overall, no difference existed between ES and the sham procedure in improving biliary SOD-related pain overall (RR 1.32, 95% CI 0.77-2.26, P = .31) and for the normal (RR 0.83, 95% CI 0.42-1.65, P = .60) and abnormal SOM subgroups (RR 1.90, 95% CI 0.84-4.29, P = .12). ES was numerically favored over the sham procedure in patients with type II (RR 2.51, 95% CI 1.32-4.81, P = .005) but not type III SOD (RR 1.02, 95% CI 0.32-3.27, P = .98). However, there was no significant subgroup difference between these type-based subgroups (P = .18, I2 = 43.2%).
Conclusion
ES does not improve biliary SOD-related pain overall or for type II vs III SOD or normal vs abnormal SOM subgroups. This meta-analysis confirms that there is no proven role for SOM or ES in managing SOD.